{"id":10423,"date":"2007-12-14T11:56:48","date_gmt":"2007-12-14T08:56:48","guid":{"rendered":"https:\/\/www.synevo.ro\/afectiuni\/profil-boli-cu-transmitere-sexuala\/"},"modified":"2020-07-10T13:21:12","modified_gmt":"2020-07-10T10:21:12","slug":"profil-boli-cu-transmitere-sexuala","status":"publish","type":"synevo_diseases","link":"https:\/\/old.synevo.md\/ru\/afectiuni\/profil-boli-cu-transmitere-sexuala\/","title":{"rendered":"Profil boli cu transmitere sexual\u0103"},"content":{"rendered":"

Infec\u0163iile cu transmitere sexual\u0103<\/strong> sunt cauzate de o varietate mare de agen\u0163i patogeni. \u00cen general, sifilisul, gonoreea \u015fi infec\u0163ia cu Chlamydia trachomatis sunt considerate principalele infec\u0163ii cu transmitere sexual\u0103. Al\u0163i agen\u0163i patogeni posibili includ: Herpes simplex virus tip 2 (HSV-2), Papilloma virus(HPV), virusul imunodeficien\u0163ei umane (HIV), virusul hepatitei tip B(HBV), Trichomonas vaginalis, HTLV-1.<\/p>

Aproximativ 340 milioane de cazuri noi<\/strong> de sifilis, gonoree, infec\u0163ii cu Chlamydia \u015fi Trichomonas, apar \u00een fiecare an la b\u0103rba\u0163ii \u015fi femeile \u00een v\u00e2rst\u0103 de 15-49 ani (WHO, 2001); prevalen\u0163a infec\u0163iilor cu transmitere sexual\u0103 continu\u0103 s\u0103 creasc\u0103 \u00een multe \u0163\u0103ri, inclusiv \u00een \u0163\u0103rile dezvoltate.<\/p>

Clinic<\/strong>: infec\u0163iile cu transmitere sexual\u0103 pot fi asimptomatice (ex. 50% din b\u0103rba\u0163ii \u015fi 75% din femeile cu infec\u0163ie cu Chlamydia sunt asimptomatici, favoriz\u00e2nd r\u0103sp\u00e2ndirea infec\u0163iei1<\/sup>), cu simptome u\u015foare \u015fi tranzitorii sau cu simptome acute (gonoree, chancroid, infec\u0163ia cu virusul Herpes simplex).<\/p>

Multe infec\u0163ii pot avea consecin\u0163e severe pe termen lung. La adul\u0163i, infec\u0163ia cu Chlamydia \u015fi Gonoreea pot conduce la complica\u0163ii ca infertilitate \u015fi sarcin\u0103 ectopic\u0103 poten\u0163ial fatal\u0103 sau afectare cronic\u0103.
Afectarea femeii gravide de unele din infec\u0163iile cu transmitere sexual\u0103 poate conduce la avorturi spontane, moarte fetal\u0103, na\u015ftere prematur\u0103, endometrita postpartum.<\/p>

Afectarea f\u0103tului \u015fi nou-n\u0103scutului poate determina afec\u0163iuni importante, unele cu poten\u0163ial letal ex. conjunctivita gonococic\u0103 \u2013 poate duce la cecitate, pneumonia cu Chlamydia \u2013 poate conduce la afectare respiratorie cronic\u0103, sifilisul congenital, encefalita herpetic\u0103.<\/p>

Infec\u0163iile cu transmitere sexual\u0103 amplific\u0103 riscul transmiterii HIV<\/strong>. Infec\u0163ia cu HPV <\/strong>este o precondi\u0163ie dovedit\u0103 pentru dezvoltarea cancerului de col uterin, care este a doua cauz\u0103 \u00een lume de mortalitate prin cancer la femei<\/strong>. 2,3<\/sup>
Av\u00e2nd \u00een vedere r\u0103sp\u00e2ndirea \u015fi consecin\u0163ele negative ale infec\u0163iilor cu transmitere sexual\u0103 asupra s\u0103n\u0103t\u0103\u0163ii \u015fi poten\u0163ialului reproductiv \u00een r\u00e2ndul popula\u0163iei, s-au elaborat protocoale, destul de asem\u0103n\u0103toare, de diagnostic \u015fi tratament standardizat (Ghidul OMS, Ghidul European, Ghidul Centrelor de Control al Maladiilor din SUA).<\/p>

Teste disponibile \u00een laboratorul Synevo:<\/strong><\/p><\/div>\n\n

\r\n
\r\n \r\n
\r\n
\r\n Chlamydia trachomatis-Anticorpi Ig A<\/a>\r\n
\r\n Pre\u021b:<\/span>\r\n 230.00 lei<\/span>\r\n <\/div>\r\n
\r\n
<\/div><\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n Chlamydia trachomatis-Anticorpi Ig G<\/a>\r\n
\r\n Pre\u021b:<\/span>\r\n 230 lei<\/span>\r\n <\/div>\r\n
\r\n
<\/div><\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n Examen microscopic pe frotiu (preparat proasp\u0103t \u0219i\/sau colorat)<\/a>\r\n
\r\n Pre\u021b:<\/span>\r\n 220.00 lei<\/span>\r\n <\/div>\r\n
\r\n
<\/div><\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n Cultura secretie uretrala (cu antibiograma dupa caz)<\/a>\r\n
\r\n Pre\u021b:<\/span>\r\n 350 lei<\/span>\r\n <\/div>\r\n
\r\n
<\/div><\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n Serologie sifilis (VDRL\/RPR si Anticorpi-Treponema pallidum)<\/a>\r\n
\r\n Pre\u021b:<\/span>\r\n 125 lei<\/span>\r\n <\/div>\r\n
\r\n
<\/div><\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n HPV ADN – detectie tipuri cu risc crescut: genotipare 16, 18<\/a>\r\n
\r\n Pre\u021b:<\/span>\r\n 695.00 lei<\/span>\r\n <\/div>\r\n
\r\n
<\/div><\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n Profil virus herpes simplex (HSV1, HSV2)-Anticorpi IgM<\/a>\r\n
\r\n Pre\u021b:<\/span>\r\n 270.00 lei<\/span>\r\n <\/div>\r\n
\r\n
<\/div><\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n Profil virus herpes simplex (HSV1, HSV2)-Anticorpi IgG<\/a>\r\n
\r\n Pre\u021b:<\/span>\r\n 270.00 lei<\/span>\r\n <\/div>\r\n
\r\n
<\/div><\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n Ag HBs (screening)<\/a>\r\n
\r\n Pre\u021b:<\/span>\r\n 225 lei<\/span>\r\n <\/div>\r\n
\r\n
<\/div><\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n Anti-HIV 1+2<\/a>\r\n
\r\n Pre\u021b:<\/span>\r\n 230 lei<\/span>\r\n <\/div>\r\n
\r\n
<\/div><\/a>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n \r\n <\/div>\r\n<\/div>\r\n\r\n